Compare · COO vs WRBY
COO vs WRBY
Side-by-side comparison of The Cooper Companies Inc. (COO) and Warby Parker Inc. (WRBY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both COO and WRBY operate in Ophthalmic Goods (Health Care), so they compete in similar markets.
- COO is the larger of the two at $19.03B, about 6.7x WRBY ($2.83B).
- Over the past year, COO is down 24.2% and WRBY is up 36.3% - WRBY leads by 60.6 points.
- COO has been more active in the news (14 items in the past 4 weeks vs 6 for WRBY).
- Both have 25 recent analyst ratings on file.
- Company
- The Cooper Companies Inc.
- Warby Parker Inc.
- Price
- $62.37-0.83%
- $23.07+4.44%
- Market cap
- $19.03B
- $2.83B
- 1M return
- -12.68%
- +7.78%
- 1Y return
- -24.22%
- +36.35%
- Industry
- Ophthalmic Goods
- Ophthalmic Goods
- Exchange
- NYSE
- NYSE
- IPO
- 2021
- News (4w)
- 14
- 6
- Recent ratings
- 25
- 25
The Cooper Companies Inc.
The Cooper Companies, Inc. operates as a medical device company worldwide. It operates through two segments, CooperVision and CooperSurgical. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides range of products and services for enhancing health of women, babies, and families, including medical devices, fertility, genomics, and diagnostics and contraception for hospitals and surgical centers, obstetricians' and gynecologists' (OB/GYNs) medical offices, and fertility clinics. In addition, the company develops mechanical surgical solutions for skin closure; and offers PARAGARD, a contraceptive, as well as provides assisted reproductive technology products, genetic screening and testing, and products within the general OB/GYN offerings. It markets its products under Biofinity, clariti 1day, MyDay, Avaira Vitality, and Proclear 1 Day brand name through a network of field sales representatives, independent agents, eye care practitioners, and distributors. The Cooper Companies, Inc. was founded in 1980 and is headquartered in San Ramon, California.
Warby Parker Inc.
Warby Parker Inc. designs, manufactures, and retails eyewear products for men and women. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as eye exams and vision tests. As of June 30, 2021, it operated 145 retail stores, which included 142 locations in the United States and 3 locations in Canada, as well as online stores. The company was formerly known as JAND, Inc. and changed its name to Warby Parker Inc. in June 2021. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.
Latest COO
- CooperCompanies Announces Release Date for Second Quarter 2026
- SEC Form 4 filed by Rosebrough Walter M Jr
- CooperVision Partners with Canadian Olympic Speed Skater Valérie Maltais on Her Continued Pursuit of Excellence on the World Stage
- CooperVision Launches MADE BETTER™ Promise Beginning with MyDay® Contact Lenses*¹
- Telix Strengthens Board with Additional Director Appointments
- The Cooper Companies Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- SEC Form 4 filed by Weiss Robert S
- SEC Form 4 filed by Rivas Maria
- SEC Form 4 filed by Jay Colleen
- SEC Form 4 filed by Carbone Barbara
Latest WRBY
- SEC Form DEFA14A filed by Warby Parker Inc.
- SEC Form DEF 14A filed by Warby Parker Inc.
- Warby Parker Launches Warby Parker Sport, Expanding into the Performance Eyewear Category
- SEC Form 4 filed by Blumenthal Neil Harris
- SEC Form 144 filed by Warby Parker Inc.
- Warby Parker to Announce First Quarter 2026 Financial Results on May 7, 2026
- Amendment: SEC Form SCHEDULE 13G/A filed by Warby Parker Inc.
- Director Raider Jeffrey Jacob sold $635,750 worth of shares (25,000 units at $25.43), decreasing direct ownership by 5% to 448,697 units (SEC Form 4)
- Co-Chief Executive Officer Blumenthal Neil Harris converted options into 13,475 shares and covered exercise/tax liability with 7,453 shares, increasing direct ownership by 14% to 50,165 units (SEC Form 4)
- Co-Chief Executive Officer Gilboa David Abraham converted options into 13,475 shares and covered exercise/tax liability with 7,453 shares, increasing direct ownership by 14% to 50,293 units (SEC Form 4)